Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Greenstein Leonard M.
Chief Financial Officer at Tarsus Pharmaceuticals. Filing since 18 Aug 2022.
CIK 0001519692
Company
Date
Role
Action
Shares
Amount
Of holding
TARS
Tarsus Pharmaceuticals, Inc.
20 Apr 2023
Chief Financial Officer
Sold on a plan
5,000
$70.10K
15.7%
TARS
Tarsus Pharmaceuticals, Inc.
23 Mar 2023
Chief Financial Officer
Sold at will
346
$4.20K
1.1%
TARS
Tarsus Pharmaceuticals, Inc.
22 Mar 2023
Chief Financial Officer
Sold at will
332
$4.20K
1.0%
TARS
Tarsus Pharmaceuticals, Inc.
21 Mar 2023
Chief Financial Officer
Sold at will
326
$4.20K
1.0%
TARS
Tarsus Pharmaceuticals, Inc.
20 Mar 2023
Chief Financial Officer
Sold at will
333
$4.20K
1.0%
TARS
Tarsus Pharmaceuticals, Inc.
17 Mar 2023
Chief Financial Officer
Sold at will
316
$4.20K
0.9%
TARS
Tarsus Pharmaceuticals, Inc.
16 Mar 2023
Chief Financial Officer
Sold, plan not stated
5,313
$71.40K
13.7%
TARS
Tarsus Pharmaceuticals, Inc.
16 Feb 2023
Chief Financial Officer
Sold, plan not stated
5,000
$75.60K
12.7%
TARS
Tarsus Pharmaceuticals, Inc.
19 Jan 2023
Chief Financial Officer
Sold, plan not stated
5,000
$72.80K
11.3%
TARS
Tarsus Pharmaceuticals, Inc.
15 Dec 2022
Chief Financial Officer
Sold, plan not stated
5,000
$73.20K
10.1%
TARS
Tarsus Pharmaceuticals, Inc.
17 Nov 2022
Chief Financial Officer
Sold, plan not stated
5,000
$82.70K
9.2%
TARS
Tarsus Pharmaceuticals, Inc.
20 Oct 2022
Chief Financial Officer
Sold, plan not stated
5,000
$79.59K
8.4%
TARS
Tarsus Pharmaceuticals, Inc.
15 Sep 2022
Chief Financial Officer
Sold, plan not stated
5,000
$80.15K
7.8%
TARS
Tarsus Pharmaceuticals, Inc.
18 Aug 2022
Chief Financial Officer
Sold, plan not stated
5,000
$81.50K
7.2%
14 decisions on file.
